Pharma DECODED
Latest edition: 22 May 2024
Share newsletter
Get the full version straight to your inbox.
Exclusive access to our best-in-class data & intelligence
Subscribe now
Spotlight
Genmab acquires biotechnology company ProfoundBio in $1.8bn deal
Genmab has gained access to ProfoundBio’s ADCs for cancer treatment.
Latest news
Lilly collaborates with Aktis to strengthen radiopharma portfolio
Aktis will receive $60m in an upfront payment from Lilly, with the biotech eligible for up to $1.1bn in milestone payments and royalties.
Alvotech and Dr Reddy's partner to commercialise AVT03
Alvotech is eligible to receive undisclosed upfront and milestone payments for the biosimilar candidate.
Roche's PI3K inhibitor secures breakthrough status in breast cancer
Roche announced an FDA breakthrough therapy designation for its inavolisib / Ibrance combination therapy.
Explainer: US Election 2024 -Biden's healthcare outlook
As the 2024 US Election begins to pick up steam the Biden administration is already trying to remind voters of past success whilst challenging healthcare pricing
J&J's Tremfya superior to Stelara in Phase II/III Crohn's disease trial
Tremfya was superior to both Stelara and placebo in all endoscopic endpoints in the Phase III portion of the Galaxi programme.
AiM Medical Robotics partners with Harvard Hospital for DBS study
The study will take place at Harvard’s Brigham and Women's Hospital and will validate AiM’s robot for deep brain stimulation in Parkinson’s.
Eli Lilly's mirikizumab shows promise in Phase III Crohn's disease trial
Mirikizumab demonstrated significant improvements in Crohn's disease patients.
In our previous edition
Pharma Decoded
AstraZeneca to establish $1.5bn ADC production site in Singapore
21 May 2024
Pharma Decoded
Sanders issues warning to Novo Nordisk amid GLP-1 drug price investigation
20 May 2024
Pharma Decoded
Patient access to medicines must be the focus of US drug pricing policy
17 May 2024
Still looking?
Search companies, themes, reports, as well as actionable data & insights spanning 22 global industries
Explorer
Access more premium companies when you subscribe to Explorer